Differing requirements for CCR4, E-selectin, and α 4β 1 for the migration of memory CD4 and activated T cells to dermal inflammation

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 337-346

  Gehad, Ahmed ^a   Al Banna, Nadia A ^a   Vaci, Maria ^a   Issekutz, Andrew C ^a   Mohan, Karkada ^a   Latta, Markus ^a   Issekutz, Thomas B ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION; TROPISM;

ANIMALS; CELL MIGRATION INHIBITION; CELL MOVEMENT; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; E-SELECTIN; IMMUNOLOGIC MEMORY; INFLAMMATION; INTEGRIN ALPHA4BETA1; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED LEW; RECEPTORS, CCR4; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIALOGLYCOPROTEINS; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 84862869507     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102315     Document Type: Article

References (52)

1. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123-128. (Pubitemid 33707929)
2. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hébert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176. (Pubitemid 30127598)
3. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568. (Pubitemid 28207705)
4. Godessart, N., and S. L. Kunkel. 2001. Chemokines in autoimmune disease. Curr. Opin. Immunol. 13: 670-675. (Pubitemid 33000160)
5. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101: 746-754. (Pubitemid 28096070)
6. Andrew, D. P., N. Ruffing, C. H. Kim, W. Miao, H. Heath, Y. Li, K. Murphy, J. J. Campbell, E. C. Butcher, and L. Wu. 2001. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J. Immunol. 166: 103-111. (Pubitemid 32038422)
7. + lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115: 640-646.
8. + T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J. Allergy Clin. Immunol. 107: 353-358.
9. Kusumoto, M., B. Xu, M. Shi, T. Matsuyama, K. Aoyama, and T. Takeuchi. 2007. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity. J. Interferon Cytokine Res. 27: 901-910. (Pubitemid 350223110)
10. Eβ7 in the pathogenesis of psoriasis vulgaris. Lab. Invest. 81: 335-347.
11. Kunkel, E. J., J. Boisvert, K. Murphy, M. A. Vierra, M. C. Genovese, A. J. Wardlaw, H. B. Greenberg, M. R. Hodge, L. Wu, E. C. Butcher, and J. J. Campbell. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160: 347-355. (Pubitemid 34052295)
12. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780. (Pubitemid 29399540)
13. Flier, J., D. M. Boorsma, P. J. van Beek, C. Nieboer, T. J. Stoof, R. Willemze, and C. P. Tensen. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194: 398-405. (Pubitemid 32782663)
14. Mohan, K., E. Cordeiro, M. Vaci, C. McMaster, and T. B. Issekutz. 2005. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur. J. Immunol. 35: 1702-1711. (Pubitemid 40862318)
15. Fuhlbrigge, R. C., J. D. Kieffer, D. Armerding, and T. S. Kupper. 1997. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389: 978-981. (Pubitemid 27485690)
16. Ohmori, K., F. Fukui, M. Kiso, T. Imai, O. Yoshie, H. Hasegawa, K. Matsushima, and R. Kannagi. 2006. Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells. Blood 107: 3197-3204.
17. Takahashi, R., Y. Mizukawa, Y. Yamazaki, K. Hayakawa, J. Hayakawa, A. Kudo, and T. Shiohara. 2003. In vitro differentiation from naive to mature E-selectin binding CD4 T cells: acquisition of skin-homing properties occurs independently of cutaneous lymphocyte antigen expression. J. Immunol. 171: 5769-5777. (Pubitemid 37467192)
18. + T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J. Immunol. 163: 466-475.
19. Biedermann, T., C. Schwärzler, G. Lametschwandtner, G. Thoma, N. Carballido-Perrig, J. Kund, J. E. de Vries, A. Rot, and J. M. Carballido. 2002. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur. J. Immunol. 32: 3171-3180. (Pubitemid 35414874)
20. + T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J. Immunol. 161: 963-970.
21. Borges, E., G. Pendl, R. Eytner, M. Steegmaier, O. Zöllner, and D. Vestweber. 1997. The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated. J. Biol. Chem. 272: 28786-28792. (Pubitemid 27517838)
22. Doebis, C., K. Siegmund, C. Loddenkemper, J. B. Lowe, A. C. Issekutz, A. Hamann, J. Huehn, and U. Syrbe. 2008. Cellular players and role of selectin ligands in leukocyte recruitment in a T-cell-initiated delayed-type hypersensitivity reaction. Am. J. Pathol. 173: 1067-1076.
23. Borges, E., W. Tietz, M. Steegmaier, T. Moll, R. Hallmann, A. Hamann, and D. Vestweber. 1997. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J. Exp. Med. 185: 573-578. (Pubitemid 27078375)
24. Issekutz, A. C., and T. B. Issekutz. 2002. The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J. Immunol. 168: 1934-1939. (Pubitemid 34135796)
25. Kulidjian, A. A., A. C. Issekutz, and T. B. Issekutz. 2002. Differential role of Eselectin and P-selectin in T lymphocyte migration to cutaneous inflammatory reactions induced by cytokines. Int. Immunol. 14: 751-760. (Pubitemid 34814635)
26. Issekutz, T. B. 1991. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: a likely role for VLA-4 in vivo. J. Immunol. 147: 4178-4184.
27. Issekutz, T. B. 1993. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am. J. Pathol. 143: 1286-1293.
28. Kane, S. V., S. Horst, W. J. Sandborn, B. Becker, B. Neis, M. Moscandrew, K. A. Hanson, W. J. Tremaine, D. H. Bruining, W. A. Faubion, et al. Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience. Inflamm. Bowel Dis.
29. Hutchinson, M. 2007. Natalizumab: a new treatment for relapsing remitting multiple sclerosis. Ther Clin Risk Manag 3: 259-268. (Pubitemid 46881453)
30. Catalina, M. D., P. Estess, and M. H. Siegelman. 1999. Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation: participation of E- and P- but not L-selectin. Blood 93: 580-589. (Pubitemid 29035739)
31. + T lymphocytes into inflamed skin. J. Immunol. 169: 4307-4313.
32. Walter, U. M., L. M. Ayer, B. A. Wolitzky, D. D. Wagner, R. O. Hynes, A. M. Manning, and A. C. Issekutz. 1997. Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in the P-selectin-deficient mouse. Hybridoma 16: 249-257. (Pubitemid 27282212)
33. Walter, U. M., L. M. Ayer, A. M. Manning, P. S. Frenette, D. D. Wagner, R. O. Hynes, B. A. Wolitzky, and A. C. Issekutz. 1997. Generation and characterization of a novel adhesion function blocking monoclonal antibody recognizing both rat and mouse E-selectin. Hybridoma 16: 355-361. (Pubitemid 27410604)
34. Walter, U. M., and A. C. Issekutz. 1997. Role of E- and P-selectin in migration of monocytes and polymorphonuclear leucocytes to cytokine and chemoattractant-induced cutaneous inflammation in the rat. Immunology 92: 290-299. (Pubitemid 27428459)
35. Issekutz, A. C., and T. B. Issekutz. 1995. Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J. Exp. Med. 181: 1197-1203.
36. Mohan, K., Z. Ding, J. Hanly, and T. B. Issekutz. 2002. IFN-γ-inducible T cell a chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-γ and TNF-α. J. Immunol. 168: 6420-6428. (Pubitemid 34624585)
37. 4 integrins regulate independent pathways of T lymphocyte recruitment in the pulmonary immune response. J. Immunol. 161: 4396-4403.
38. Morimoto, Y., Y. Bian, P. Gao, Y. Yashiro-Ohtani, X. Y. Zhou, S. Ono, H. Nakahara, M. Kogo, T. Hamaoka, and H. Fujiwara. 2005. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development. J. Leukoc. Biol. 78: 753-761. (Pubitemid 41292098)
39. Sallusto, F., E. Kremmer, B. Palermo, A. Hoy, P. Ponath, S. Qin, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29: 2037-2045. (Pubitemid 29265560)
40. Campbell, J. J., D. J. O'Connell, and M. A. Wurbel. 2007. Cutting edge: chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J. Immunol. 178: 3358-3362. (Pubitemid 46417598)
41. Nouri-Aria, K. T., D. Wilson, J. N. Francis, L. A. Jopling, M. R. Jacobson, M. R. Hodge, D. P. Andrew, S. J. Till, E. M. Varga, T. J. Williams, et al. 2002. CCR4 in human allergen-induced late responses in the skin and lung. Eur. J. Immunol. 32: 1933-1938. (Pubitemid 34814549)
42. Colantonio, L., H. Recalde, F. Sinigaglia, and D. D'Ambrosio. 2002. Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells. Eur. J. Immunol. 32: 1264-1273. (Pubitemid 34546253)
43. + T cell differentiation and bridges central and peripheral functions. J. Immunol. 171: 2812-2824.
44. Homey, B., H. Alenius, A. Müller, H. Soto, E. P. Bowman, W. Yuan, L. McEvoy, A. I. Lauerma, T. Assmann, E. Bünemann, et al. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8: 157-165. (Pubitemid 34155127)
45. Vestergaard, C., M. Deleuran, B. Gesser, and C. Grønhøj Larsen. 2003. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br. J. Dermatol. 149: 457-463. (Pubitemid 37281575)
46. Reiss, Y., A. E. Proudfoot, C. A. Power, J. J. Campbell, and E. C. Butcher. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194: 1541-1547. (Pubitemid 33081528)
47. Tubo, N. J., J. B. McLachlan, and J. J. Campbell. 2011. Chemokine receptor requirements for epidermal T-cell trafficking. Am. J. Pathol. 178: 2496-2503.
48. Issekutz, A. C., and T. B. Issekutz. 2001. The role of E-selectin and VLA-4 in T lymphocyte migration to dermal inflammation. J. Immunol. 168: 1934-1939.
49. Issekutz, T. B. 1992. Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J. Immunol. 149: 3394-3402.
50. + T lymphocytes. J. Invest. Dermatol. 117: 569-575.
51. Knibbs, R. N., R. A. Craig, S. Natsuka, A. Chang, M. Cameron, J. B. Lowe, and L. M. Stoolman. 1996. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J. Cell Biol. 133: 911-920. (Pubitemid 26160990)
52. Wagers, A. J., C. M. Waters, L. M. Stoolman, and G. S. Kansas. 1998. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on α1,3-fucosyltransferase VII gene expression. J. Exp. Med. 188: 2225-2231. (Pubitemid 29028495)